Literature DB >> 17213812

A short N-terminal sequence of PTEN controls cytoplasmic localization and is required for suppression of cell growth.

G Denning1, B Jean-Joseph, C Prince, D L Durden, P K Vogt.   

Abstract

Phosphatase and tensin homolog deleted on chromosome 10 (PTEN) is an important negative regulator of cell growth and a tumor suppressor. Its growth-attenuating activity is based on the dephosphorylation of phosphatidylinositol 3,4,5-trisphosphate (PIP3), an essential second messenger for the phosphoinositide 3-kinase/Akt signaling pathway. This activity may require localization of PTEN to cytoplasmic membranes. Yet PTEN can also localize to the cell nucleus where its functions remain unclear. Here we present data that define a short sequence in the N-terminal region of PTEN required for cytoplasmic localization. We will refer to this sequence as cytoplasmic localization signal (CLS). It could function as a non-canonical signal for nuclear export or as a cytoplasmic retention signal of PTEN. Mutations within the CLS induce nuclear localization and impair growth suppressive activities of PTEN while preserving lipid phosphatase activity. We propose that nuclear localization of PTEN is not compatible with plasma membrane-targeted growth suppressive functions of PTEN.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17213812     DOI: 10.1038/sj.onc.1210175

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  54 in total

1.  PTEN activation through K163 acetylation by inhibiting HDAC6 contributes to tumour inhibition.

Authors:  Z Meng; L-F Jia; Y-H Gan
Journal:  Oncogene       Date:  2015-08-17       Impact factor: 9.867

2.  A pathogenic role for germline PTEN variants which accumulate into the nucleus.

Authors:  Janire Mingo; Isabel Rodríguez-Escudero; Sandra Luna; Teresa Fernández-Acero; Laura Amo; Amy R Jonasson; Roberto T Zori; José I López; María Molina; Víctor J Cid; Rafael Pulido
Journal:  Eur J Hum Genet       Date:  2018-04-30       Impact factor: 4.246

3.  A motor driving PTEN.

Authors:  Jing Zhou; Luis F Parada
Journal:  Nat Cell Biol       Date:  2009-10       Impact factor: 28.824

4.  Mechanistic analysis of a DNA damage-induced, PTEN-dependent size checkpoint in human cells.

Authors:  Jung-Sik Kim; Xuehua Xu; Huifang Li; David Solomon; William S Lane; Tian Jin; Todd Waldman
Journal:  Mol Cell Biol       Date:  2011-05-02       Impact factor: 4.272

Review 5.  Balancing Proliferation and Connectivity in PTEN-associated Autism Spectrum Disorder.

Authors:  Amanda K Tilot; Thomas W Frazier; Charis Eng
Journal:  Neurotherapeutics       Date:  2015-07       Impact factor: 7.620

6.  ΔNp63α represses nuclear translocation of PTEN by inhibition of NEDD4-1 in keratinocytes.

Authors:  Mary K Leonard; Natasha T Hill; Ethan D Grant; Madhavi P Kadakia
Journal:  Arch Dermatol Res       Date:  2013-04-16       Impact factor: 3.017

Review 7.  Regulation and modulation of PTEN activity.

Authors:  Elahe Naderali; Amir Afshin Khaki; Jafar Soleymani Rad; Alireza Ali-Hemmati; Mohammad Rahmati; Hojjatollah Nozad Charoudeh
Journal:  Mol Biol Rep       Date:  2018-08-25       Impact factor: 2.316

Review 8.  Oncogenic PTEN functions and models in T-cell malignancies.

Authors:  M Tesio; A Trinquand; E Macintyre; V Asnafi
Journal:  Oncogene       Date:  2015-11-30       Impact factor: 9.867

9.  Epidermal growth factor receptor and PTEN modulate tissue factor expression in glioblastoma through JunD/activator protein-1 transcriptional activity.

Authors:  Yuan Rong; Vladimir E Belozerov; Carol Tucker-Burden; Gang Chen; Donald L Durden; Jeffrey J Olson; Erwin G Van Meir; Nigel Mackman; Daniel J Brat
Journal:  Cancer Res       Date:  2009-03-10       Impact factor: 12.701

10.  Germline and somatic cancer-associated mutations in the ATP-binding motifs of PTEN influence its subcellular localization and tumor suppressive function.

Authors:  Glenn P Lobo; Kristin A Waite; Sarah M Planchon; Todd Romigh; Najah T Nassif; Charis Eng
Journal:  Hum Mol Genet       Date:  2009-05-20       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.